E-LIB Suche - Ergebnisse für: Meyer, Pierre‐François

1

Real-World Safety and Effectiveness of a Bevacizumab Biosim..:

Cheung, Winson Y. ; Samimi, Setareh ; Ma, Kim...
Clinical Colorectal Cancer. 23 (2024) 1 - p. 46-57.e4 , 2024

2

Longitudinal blood biomarker trajectories in preclinical Al..:

Yakoub, Yara ; Ashton, Nicholas J. ; Strikwerda‐Brown, Cherie...
Alzheimer's & Dementia. 19 (2023) 12 - p. 5620-5631 , 2023

Link: https://doi.org/10.1002/..

3

Longitudinal Blood Biomarker Trajectories in Preclinical Al..:

Yakoub, Yara ; Ashton, Nicholas J. ; Karikari, Thomas K...
Alzheimer's & Dementia. 18 (2022) S6 - p. , 2022

Link: https://doi.org/10.1002/..

4

Longitudinal Blood Biomarker Trajectories in Preclinical Al..:

Yakoub, Yara ; Ashton, Nicholas J. ; Karikari, Thomas K...
Alzheimer's & Dementia. 18 (2022) S1 - p. , 2022

Link: https://doi.org/10.1002/..

5

Plasma p‐tau231, p‐tau181, PET Biomarkers, and Cognitive Ch..:

Meyer, Pierre‐François ; Ashton, Nicholas J. ; Karikari, Thomas K....
Annals of Neurology. 91 (2022) 4 - p. 548-560 , 2022

Link: https://doi.org/10.1002/..

6

Vascular risk factors are associated with a decline in rest..:

Köbe, Theresa ; Binette, Alexa Pichet ; Vogel, Jacob W....
NeuroImage. 231 (2021) - p. 117832 , 2021

Link: https://doi.org/10.1016/..

7

Association of a Total Cholesterol Polygenic Score with Cho..:

Nilsson, Nathalie I. V. ; Picard, Cynthia ; Labonté, Anne...
Genes. 12 (2021) 11 - p. 1805 , 2021

Link: https://doi.org/10.3390/..

8

Dementia risk reduction: why haven't the pharmacological ri..:

Peters, Ruth ; Breitner, John ; James, Sarah...
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 7 (2021) 1 - p. , 2021

Link: https://doi.org/10.1002/..

9

The epidemiology is promising, but the trial evidence is we..:

Peters, Ruth ; Dodge, Hiroko H. ; James, Sarah...
Alzheimer's & Dementia. 18 (2021) 3 - p. 507-512 , 2021

Link: https://doi.org/10.1002/..

10

Intermediate flortaucipir uptake is associated with Aβ-PET ..:

McSweeney, Melissa ; Pichet Binette, Alexa ; Meyer, Pierre-François...
Neurology. 94 (2020) 11 - p. , 2020

Link: https://doi.org/10.1212/..

11

Author response: INTREPAD: A randomized trial of naproxen t..:

Breitner, John ; Meyer, Pierre-Francois
Neurology. 94 (2020) 13 - p. 594-594 , 2020

Link: https://doi.org/10.1212/..

12

IC‐P‐091: CEREBROSPINAL FLUID AND PET MEASURES OF TAU PATHO..:

Meyer, Pierre-François ; Binette, Alexa Pichet ; Breitner, John C.S...
Alzheimer's & Dementia. 15 (2019) 7S_Part_2 - p. , 2019

Link: https://doi.org/10.1016/..

13

O4‐11‐06: NSAIDS FOR AD PREVENTION? NAPROXEN ENTERS THE CNS..:

Meyer, Pierre-François ; Labonte, Anne ; Rosa-Neto, Pedro...
Alzheimer's & Dementia. 15 (2019) 7S_Part_24 - p. , 2019

Link: https://doi.org/10.1016/..

14

INTREPAD: A randomized trial of naproxen to slow progress o..:

Meyer, Pierre-François ; Tremblay-Mercier, Jennifer ; Leoutsakos, Jeannie...
Neurology. 92 (2019) 18 - p. , 2019

Link: https://doi.org/10.1212/..

15

Hypothesis: cerebrospinal fluid protein markers suggest a p..:

Meyer, Pierre‐François ; Savard, Melissa ; Poirier, Judes...
Alzheimer's & Dementia. 15 (2019) 9 - p. 1160-1171 , 2019

Link: https://doi.org/10.1016/..